Changcun Liu

451 total citations
20 papers, 347 citations indexed

About

Changcun Liu is a scholar working on Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Biomaterials. According to data from OpenAlex, Changcun Liu has authored 20 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biomaterials. Recurrent topics in Changcun Liu's work include Radiopharmaceutical Chemistry and Applications (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Changcun Liu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Changcun Liu collaborates with scholars based in China, United States and France. Changcun Liu's co-authors include Lingzhou Zhao, Jinhua Zhao, Xiangyang Shi, Du Li, Shihui Wen, Qinghua Zhao, Yan Xing, Wenli Qiao, Jingchao Li and Na Sun and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Nanoscale.

In The Last Decade

Changcun Liu

19 papers receiving 340 citations

Peers

Countries citing papers authored by Changcun Liu

Since Specialization

Citations

This map shows the geographic impact of Changcun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changcun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changcun Liu more than expected).

Fields of papers citing papers by Changcun Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changcun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changcun Liu. The network helps show where Changcun Liu may publish in the future.

Co-authorship network of co-authors of Changcun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Changcun Liu. A scholar is included among the top collaborators of Changcun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changcun Liu. Changcun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two Cases of Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma in 18F-FDG PET/CT 2024 ·Clinical Nuclear Medicine ·Ru Wang, Haidong Cai, Changcun Liu, Zhongwei Lv, Chao Ma	1
2	Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), Changcun Liu, Shan Wu, Na Sun, Lingzhou Zhao, Jingchao Li, Yan Xing, Jinhua Zhao	22
3	A Solid Pseudopapillary Tumor of the Pancreas Incidentally Detected by 68Ga-Pentixafor PET/CT in a Patient With Primary Aldosteronism 2024 ·Clinical Nuclear Medicine ·Xiang Chen, Yan Xing, Changcun Liu, Rui Zhang, Jinhua Zhao	0
4	Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial 2024 ·Breast Cancer Research ·Lingzhou Zhao, Yan Xing, Changcun Liu, (unknown), (unknown), Zhen Cheng, Jinhua Zhao	9
5	Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression 2023 ·Frontiers in Bioengineering and Biotechnology ·Xiaoying Wang, Liyun Zhu, (unknown), Lingzhou Zhao, Jingchao Li, Changcun Liu	4
6	131I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer 2023 ·International Journal of Nanomedicine ·Lingzhou Zhao, Jiali Gong, (unknown), Changcun Liu, (unknown), Yan Xing, Jinhua Zhao	17
7	Second near-infrared photoactivatable nanomedicines for enhanced photothermal–chemodynamic therapy of cancer 2023 ·Journal of Materials Chemistry B ·Shunli Wu, Changcun Liu, Wenjuan Li, Chenxi Zhang, Dagui Chen, Can Xu, Li Su, Xiuhui Wang	5
8	Albumin-Stabilized Manganese Oxide/Semiconducting Polymer Nanocomposites for Photothermal-Chemodynamic Therapy of Hepatic Carcinoma 2022 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Changcun Liu, Jingyi Zhu, Mengbin Ding, Zhen Zhang, Jingchao Li, Qin Zhang	6
9	The r1 relaxivity and T1 imaging properties of dendrimer-based manganese and gadolinium chelators in magnetic resonance imaging 2022 ·Frontiers in Bioengineering and Biotechnology ·Kai Liu, Changcun Liu, Jindong Xia	2
10	Water absorption rates and mechanical properties of material extrusion-printed continuous carbon fiber-reinforced nylon composites 2022 ·Journal of Materials Research and Technology ·Anfu Guo, Changcun Liu, Shuo Li, Xiaoyan Zhou, Jin Wang, Shaoqing Wang, (unknown), Yingbin Hu	19
11	Prodrug and Glucose Oxidase Coloaded Photodynamic Hydrogels for Combinational Therapy of Melanoma 2022 ·ACS Biomaterials Science & Engineering ·(unknown), Changcun Liu, Yue Wang, Mengbin Ding, Ningyue Yu, Dongliang Liu, Qin Zhang, Jingchao Li	14
12	Development of a ^99mTc-Labeled Single-Domain Antibody for SPECT/CT Assessment of HER2 Expression in Breast Cancer 2021 ·Molecular Pharmaceutics ·Lingzhou Zhao, Changcun Liu, Yan Xing, (unknown), Jim O’Doherty, Wenhua Huang, Jinhua Zhao	32
13	LyP-1-Modified Multifunctional Dendrimers for Targeted Antitumor and Antimetastasis Therapy 2020 ·ACS Applied Materials & Interfaces ·Ningning Song, Lingzhou Zhao, Xiao‐Ying Xu, (unknown), Changcun Liu, Na Sun, (unknown), Xiangyang Shi, Jinhua Zhao	29
14	A novel Buthus martensii Karsch chlorotoxin derivative for glioma SPECT imaging 2020 ·New Journal of Chemistry ·Lingzhou Zhao, Jingyi Zhu, Tiantian Wang, Changcun Liu, Ningning Song, Shan Wu, Wenli Qiao, (unknown), (unknown), Jinhua Zhao	2
15	SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin 2017 ·Journal of Neuro-Oncology ·Wenli Qiao, Lingzhou Zhao, Shan Wu, Changcun Liu, (unknown), Yan Xing, Jinhua Zhao	9
16	A promising dual mode SPECT/CT imaging platform based on^99mTc-labeled multifunctional dendrimer-entrapped gold nanoparticles 2017 ·Journal of Materials Chemistry B ·Shihui Wen, Lingzhou Zhao, Qinghua Zhao, Du Li, Changcun Liu, (unknown), Mingwu Shen, Jean‐Pierre Majoral, Serge Mignani, Jinhua Zhao, Xiangyang Shi	38
17	LAPONITE-Polyethylenimine Based Theranostic Nanoplatform for Tumor-Targeting CT Imaging and Chemotherapy 2016 ·ACS Biomaterials Science & Engineering ·Ying Zhuang, Lingzhou Zhao, Linfeng Zheng, Yong Hu, Ling Ding, Xin Li, Changcun Liu, Jinhua Zhao, Xiangyang Shi, Rui Guo	47
18	¹³¹ I-Labeled Multifunctional Dendrimers Modified with BmK CT for Targeted SPECT Imaging and Radiotherapy of Gliomas 2016 ·Nanomedicine ·(unknown), Jingyi Zhu, Lingzhou Zhao, Zhijuan Xiong, Yueqin Tang, Changcun Liu, (unknown), Wenli Qiao, Xiangyang Shi, Jinhua Zhao	42
19	Ultrastable polyethyleneimine-stabilized gold nanoparticles modified with polyethylene glycol for blood pool, lymph node and tumor CT imaging 2016 ·Nanoscale ·Yongxing Zhang, Shihui Wen, Lingzhou Zhao, Du Li, Changcun Liu, (unknown), Xiang Gao, (unknown), Nan Ma, Jinhua Zhao, Xiangyang Shi, Qinghua Zhao	37
20	Structure-Function Analysis of Porcine Cytochrome P450 3A29 in the Hydroxylation of T-2 Toxin as Revealed by Docking and Mutagenesis Studies 2014 ·PLoS ONE ·Guyue Cheng, Changcun Liu, Xu Wang, Hongmin Ma, Yuanhu Pan, Lingli Huang, Haihong Hao, Menghong Dai, Zonghui Yuan	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact